Calloway's Nursery Inc. CLWY
—
5.51
0.00
0.00%
as of 24 Sep
- Market cap
- —
- P/E
- 4.9×
Follow CLWY
| Mar '23 | Dec '22 | Sep '22 | Jun '22 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
12.09 | — | — | — |
+8 more quarters Free account |
P/S ratio |
1.39 | — | — | — | |
P/FCF ratio |
8.94 | — | — | — | |
P/Operating CF |
14.10 | — | — | — | |
P/B ratio |
3.90 | — | — | — | |
Price to Tangible BV |
3.90 | — | — | — | |
EV/Sales |
1.60 | — | — | — | |
EV/EBITDA |
8.62 | — | — | — | |
EV/Operating CF |
8.92 | — | — | — | |
EV/FCF |
10.26 | — | — | — | |
Quick Ratio |
0.86 | — | 0.84 | 1.15 | |
Current Ratio |
1.52 | — | 1.67 | 1.85 | |
Net Debt/EBITDA |
4.87 | — | 0.00 | 0.00 | |
Debt/Assets |
35.34% | 0.00% | 32.79% | 36.53% | |
Debt/Equity |
1.12 | — | 0.98 | 1.04 | |
Asset Turnover |
0.94 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
4.67 | — | 0.00 | 0.00 | |
Capex/Depreciation |
(0.30) | — | (0.33) | (0.82) | |
Interest Coverage |
0.00 | — | — | — | |
Research and Development Expense of Revenue |
0.00% | — | — | — | |
Selling, General and Administrative Expense of Revenue |
40.67% | — | — | — | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | — | — | — | |
Graham Net Nets |
(0.29) | — | — | — | |
Graham Number |
9.47 | — | — | — | |
Earnings Yield |
8.27% | — | — | — | |
Free Cash Flow Yield |
11.19% | — | — | — | |
Revenue per Share |
2.73 | — | — | — | |
Operating CF per Share |
0.97 | — | 0.00 | 0.00 | |
Capex per Share |
(0.03) | — | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.94 | — | 0.00 | 0.00 | |
Cash per Share |
1.90 | — | 0.00 | 0.00 | |
Shareholders Equity per Share |
3.52 | — | 0.00 | 0.00 | |
Interest Debt per Share |
0.00 | — | 0.00 | 0.00 | |
Book value per Share |
3.52 | — | 0.00 | 0.00 | |
Free Cash Flow |
7.19 | — | (4.32) | 7.55 | |
Working Capital |
9.47 | — | 9.00 | 11.52 | |
Capital Expenditures |
(0.23) | — | (0.26) | (0.60) | |
Net Current Asset Value |
(30.17) | — | (31.63) | (29.77) | |
EV/EBIT |
10.12 | — | — | — | |
Capex to Sales |
0.01 | — | 0.00 | 0.00 | |
Net Profit Margin |
7.64% | — | — | — | |
Price to Operating Income |
8.81 | — | — | — | |
| Other line items | |||||
Average Receivables |
0.93 | — | 0.69 | 0.94 | |
Average Payables |
13.17 | — | 12.12 | 14.38 | |
Average Inventory |
9.11 | — | 8.03 | 7.78 | |
Average Assets |
80.09 | 0.00 | 78.71 | 84.86 | |
Average Common Equity |
28.05 | — | 29.94 | 29.04 |
Columns are period end dates